Connection
Matthew Griffith to Bronchodilator Agents
This is a "connection" page, showing publications Matthew Griffith has written about Bronchodilator Agents.
|
|
Connection Strength |
|
|
|
|
|
0.401 |
|
|
|
-
Griffith MF, Chen HP, Bekelman DB, Feemster LC, Spece LJ, Donovan LM, Au DH, Carey EP. Comorbid Anxiety and Depression, Though Underdiagnosed, Are Not Associated with High Rates of Low-Value Care in Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2021 03; 18(3):442-451.
Score: 0.171
-
Griffith MF, Feemster LC, Donovan LM, Spece LJ, Krishnan JA, Lindenauer PK, McBurnie MA, Mularski RA, Au DH. Poor Metered-Dose Inhaler Technique Is Associated with Overuse of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2019 06; 16(6):765-768.
Score: 0.151
-
Duan KI, Spece LJ, Wong ES, Feemster LC, Donovan LM, Griffith MF, Keller TL, Bryant AD, Au DH. Low-Value Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease and the Association with Healthcare Utilization and Costs. Ann Am Thorac Soc. 2021 06; 18(6):989-996.
Score: 0.043
-
Spece LJ, Donovan LM, Griffith MF, Collins MP, Feemster LC, Au DH. Quality of Care Delivered to Veterans with COPD Exacerbation and the Association with 30-Day Readmission and Death. COPD. 2018 10; 15(5):489-495.
Score: 0.036
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|